19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mfn2 deletion in brown adipose tissue protects from insulin resistance and impairs thermogenesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BAT‐controlled thermogenic activity is thought to be required for its capacity to prevent the development of insulin resistance. This hypothesis predicts that mediators of thermogenesis may help prevent diet‐induced insulin resistance. We report that the mitochondrial fusion protein Mitofusin 2 (Mfn2) in BAT is essential for cold‐stimulated thermogenesis, but promotes insulin resistance in obese mice. Mfn2 deletion in mice through Ucp1‐cre ( BAT‐Mfn2‐ KO) causes BAT lipohypertrophy and cold intolerance. Surprisingly however, deletion of Mfn2 in mice fed a high fat diet ( HFD) results in improved insulin sensitivity and resistance to obesity, while impaired cold‐stimulated thermogenesis is maintained. Improvement in insulin sensitivity is associated with a gender‐specific remodeling of BAT mitochondrial function. In females, BAT mitochondria increase their efficiency for ATP‐synthesizing fat oxidation, whereas in BAT from males, complex I‐driven respiration is decreased and glycolytic capacity is increased. Thus, BAT adaptation to obesity is regulated by Mfn2 and with BAT‐Mfn2 absent, BAT contribution to prevention of insulin resistance is independent and inversely correlated to whole‐body cold‐stimulated thermogenesis.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Mitochondrial dynamics in mammalian health and disease.

          The meaning of the word mitochondrion (from the Greek mitos, meaning thread, and chondros, grain) illustrates that the heterogeneity of mitochondrial morphology has been known since the first descriptions of this organelle. Such a heterogeneous morphology is explained by the dynamic nature of mitochondria. Mitochondrial dynamics is a concept that includes the movement of mitochondria along the cytoskeleton, the regulation of mitochondrial architecture (morphology and distribution), and connectivity mediated by tethering and fusion/fission events. The relevance of these events in mitochondrial and cell physiology has been partially unraveled after the identification of the genes responsible for mitochondrial fusion and fission. Furthermore, during the last decade, it has been identified that mutations in two mitochondrial fusion genes (MFN2 and OPA1) cause prevalent neurodegenerative diseases (Charcot-Marie Tooth type 2A and Kjer disease/autosomal dominant optic atrophy). In addition, other diseases such as type 2 diabetes or vascular proliferative disorders show impaired MFN2 expression. Altogether, these findings have established mitochondrial dynamics as a consolidated area in cellular physiology. Here we review the most significant findings in the field of mitochondrial dynamics in mammalian cells and their implication in human pathologies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Metabolic signaling in fuel-induced insulin secretion.

            The pancreatic islet β cell senses circulating levels of calorigenic nutrients to secrete insulin according to the needs of the organism. Altered insulin secretion is linked to various disorders such as diabetes, hypoglycemic states, and cardiometabolic diseases. Fuel stimuli, including glucose, free fatty acids, and amino acids, promote insulin granule exocytosis primarily via their metabolism in β cells and the production of key signaling metabolites. This paper reviews our current knowledge of the pathways involved in both positive and negative metabolic signaling for insulin secretion and assesses the role of established and candidate metabolic coupling factors, keeping recent developments in focus. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Vascular rarefaction mediates whitening of brown fat in obesity.

              Brown adipose tissue (BAT) is a highly vascularized organ with abundant mitochondria that produce heat through uncoupled respiration. Obesity is associated with a reduction of BAT function; however, it is unknown how obesity promotes dysfunctional BAT. Here, using a murine model of diet-induced obesity, we determined that obesity causes capillary rarefaction and functional hypoxia in BAT, leading to a BAT "whitening" phenotype that is characterized by mitochondrial dysfunction, lipid droplet accumulation, and decreased expression of Vegfa. Targeted deletion of Vegfa in adipose tissue of nonobese mice resulted in BAT whitening, supporting a role for decreased vascularity in obesity-associated BAT. Conversely, introduction of VEGF-A specifically into BAT of obese mice restored vascularity, ameliorated brown adipocyte dysfunction, and improved insulin sensitivity. The capillary rarefaction in BAT that was brought about by obesity or Vegfa ablation diminished β-adrenergic signaling, increased mitochondrial ROS production, and promoted mitophagy. These data indicate that overnutrition leads to the development of a hypoxic state in BAT, causing it to whiten through mitochondrial dysfunction and loss. Furthermore, these results link obesity-associated BAT whitening to impaired systemic glucose metabolism.
                Bookmark

                Author and article information

                Contributors
                mliesa@mednet.ucla.edu
                oshirihai@mednet.ucla.edu
                Journal
                EMBO Rep
                EMBO Rep
                10.1002/(ISSN)1469-3178
                EMBR
                embor
                EMBO Reports
                John Wiley and Sons Inc. (Hoboken )
                1469-221X
                1469-3178
                24 May 2017
                July 2017
                24 May 2017
                : 18
                : 7 ( doiID: 10.1002/embr.v18.7 )
                : 1123-1138
                Affiliations
                [ 1 ] Obesity Research Center Department of Medicine Boston University School of Medicine Boston MA USA
                [ 2 ] Division of Endocrinology Department of Medicine David Geffen School of Medicine at UCLA Los Angeles CA USA
                [ 3 ] Biochemistry Department Boston University School of Medicine Boston MA USA
                [ 4 ] Renal Section Department of Medicine Boston University School of Medicine Boston MA USA
                [ 5 ] Laboratório de Bioquímica de Resposta ao Estresse Instituto de Bioquímica Médica Leopoldo de Meis Universidade Federal do Rio de Janeiro Rio de Janeiro RJ Brazil
                [ 6 ] Department of Clinical Biochemistry School of Medicine Ben Gurion University Beer‐Sheva Israel
                Author notes
                [*] [* ] Corresponding author. Tel: +1 310‐206‐7319; E‐mail: mliesa@ 123456mednet.ucla.edu

                Corresponding author. Tel: +1 617 230 8570; E‐mail: oshirihai@ 123456mednet.ucla.edu

                Author information
                http://orcid.org/0000-0002-5909-8570
                http://orcid.org/0000-0001-8466-3431
                Article
                EMBR201643827
                10.15252/embr.201643827
                5887905
                28539390
                e70a70e3-5200-4d7a-a7a7-b92d126563e2
                © 2017 The Authors. Published under the terms of the CC BY 4.0 license

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 15 December 2016
                : 03 April 2017
                : 10 April 2017
                Page count
                Figures: 8, Tables: 0, Pages: 16, Words: 11855
                Funding
                Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
                Award ID: 5‐R01DK099618‐02
                Funded by: MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
                Award ID: 229526/2013‐6
                Funded by: NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
                Award ID: 5‐RO1DK56690
                Award ID: DK46220
                Categories
                Article
                Articles
                Custom metadata
                2.0
                embr201643827
                July 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.4 mode:remove_FC converted:06.04.2018

                Molecular biology
                brown adipose tissue,insulin resistance,mitofusin 2,obesity,thermogenesis,membrane & intracellular transport,metabolism

                Comments

                Comment on this article